English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

ROPOFOL is a deservedly popular anesthetic agent in pediatric practice, with the well-known benefits of smooth induction characteristics, antiemetic effect, rapid recovery and pleasant emergence. The drug appears to have a wide margin of safety and is less likely to cause significant hypotension than in the elderly population. With the exception of concerns that have been raised with its use for long-term sedation in the pediatric critical care environment, 1 there appear to be few safety issues to unduly concern the anesthesiologist. Minor complications are a different issue. Most of these, such as excitatory events upon induction, are generally of a trivial nature, but the troublesome issue of pain on injection still remains and has never been consistently eradicated. 2

Are children just little adults when it comes to propofol injection pain?